# Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome

> **NCT03118908** · NA · COMPLETED · sponsor: **I.M. Sechenov First Moscow State Medical University** · enrollment: 107 (actual)

## Conditions studied

- Climacteric Syndrome
- Menopause

## Interventions

- **DIETARY_SUPPLEMENT:** Amberen
- **DIETARY_SUPPLEMENT:** Smart B
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03118908
- **Lead sponsor:** I.M. Sechenov First Moscow State Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-24
- **Primary completion:** 2017-10-10
- **Final completion:** 2017-10-10
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2017-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03118908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03118908, "Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03118908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*